Picture ConsulTech GmbH RnD Credit Germany 650x80px
Organisation › Details

Genespire S.r.l.

Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases. Based in Milan, Italy, Genespire was founded in March 2020 by the gene therapy pioneer Prof. Luigi Naldini, Dr. Alessio Cantore, Fondazione Telethon and Ospedale San Raffaele. It is a spin-off of SR-Tiget, a world leading cell and gene therapy research institute and is backed by Sofinnova Partners. *


Period Start 2020-03-01 established (s-off
  Predecessor San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET)
Product Industry gene therapy
Persons Person Berretta, Julia (Epsilen Bio 202006– CEO + Genespire 202004– CEO before Cellectis 2014–201812 VP BusDev)
  Person 2 Naldini, Luigi (San Raffaele 201909 Director of SR-TIGET + Genenta Co-Founder)
Region Region Milano (Milan)
  Country Italy
  Street 8 Via Vincenzo Gioberti
  City 20123 Milano
  Tel +39-02-83991300
    Address record changed: 2020-05-15
Basic data Employees n. a.
    * Document for �About Section�: Genespire S.r.l.. (4/29/20). "Press Release: Genespire Secures €16 Million Series A Financing from Sofinnova Partners to Advance Transformative Gene Therapies. Biotech Executive, Julia Berretta, Ph.D., Is Named Chief Executive Officer". Milan.
Record changed: 2020-08-04


Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for Genespire S.r.l.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [iito] No Content Marketing 650x80px

» top